Figure 3.

Evolution of MG-ADL reported by patient via myMGverse app, ongoing use since October 2025. The blue arrows represent every efgartigimod dose (weekly dose for four weeks).

Evolution of MG-ADL reported by patient via myMGverse app, ongoing use since October 2025. The blue arrows represent every efgartigimod dose (weekly dose for four weeks).